People at high risk of pancreatic cancer are often monitored with imaging and other tests that can be invasive, expensive, ...

Pancreatic cancer blood test PANXEON detected 87% of early-stage cases in a Nature Medicine study, offering a potential triage tool for high-risk patients.

Patients most likely to benefit from the blood test include those with a higher genetic risk, a family history of pancreatic ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...

Exocrine pancreatic insufficiency (EPI) develops when the pancreas can’t make enough digestive enzymes to allow the absorption of crucial nutrients from food. This can lead to malnutrition and other ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers. Researchers at Oregon Health & Science University have ...

If your doctor suspects you may have exocrine pancreatic insufficiency (EPI), they’ll order a range of blood tests to check nutrient and enzyme levels. Share on Pinterest andresr/Getty Images While ...

Pancreatic cancer is one of the hardest cancers to treat because it is often discovered only after it has spread. Early ...

Exocrine pancreatic insufficiency (EPI) causes clay-colored, greasy stools that smell foul. A stool test to check for low levels of the elastase enzyme can help diagnose the condition. The pancreas ...

The experimental blood test is called PANXEON. It detected about 87% of stage one and stage two pancreatic cancers. That is good news because these are earlier stages.